XML 40 R25.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Earnings Per Share | 12 Months Ended
--- | ---
Dec. 31, 2021
Earnings Per Share [Abstract] |
Earnings Per Share | Earnings Per ShareBasic net income per share is calculated by dividing net income by the weighted-average number of shares of the Company’s common stock issued and outstanding during a certain period. Diluted net income per share is calculated using the weighted-average number of common and potentially dilutive common shares outstanding during the period, using the as-if converted method for preferred stock and the treasury stock method for options and common stock warrants. As of December 31, 2021, 2020, and 2019, APC held 10,925,702, 12,323,164 and 17,290,317 shares, respectively, of ApolloMed's common stock, which are treated as treasury shares for accounting purposes and not included in the number of shares of common stock outstanding used to calculate earnings per share (see Note 12 — “Mezzanine and Shareholders’ Equity”). The non-controlling interests in APC are allocated their share of ApolloMed’s income from APC’s ownership of ApolloMed common stock and this is included in the net income attributable to non-controlling interests on the consolidated statements of income. Therefore, none of the shares of ApolloMed held by APC are considered outstanding for the purposes of basic or diluted earnings per share computation. Below is a summary of the earnings per share computations:
|  | Years ended December 31,
|  | 2021 |  | 2020 |  | 2019
Earnings per share – basic |  | $ | 1.69 |  |  | $ | 1.04 |  |  | $ | 0.41 |
Earnings per share – diluted |  | $ | 1.63 |  |  | $ | 1.01 |  |  | $ | 0.39 |
Weighted-average shares of common stock outstanding – basic |  | 43,828,664 |  |  | 36,527,672 |  |  | 34,708,429 |
Weighted-average shares of common stock outstanding – diluted |  | 45,403,085 |  |  | 37,448,430 |  |  | 36,403,279 |
Below is a summary of the shares included in the diluted earnings per share computations:
|  | Years ended December 31,
|  | 2021 |  | 2020 |  | 2019
Weighted-average shares of common stock outstanding – basic |  | 43,828,664 |  |  | 36,527,672 |  |  | 34,708,429 |
Stock options |  | 495,618 |  |  | 182,999 |  |  | 295,672 |
Warrants |  | 819,151 |  |  | 717,029 |  |  | 1,384,078 |
Management restricted stock awards |  | 23,824 |  |  | 7,242 |  |  | 15,100 |
Executive restricted stock awards |  | 235,828 |  |  | 13,488 |  |  | — |
Weighted-average shares of common stock outstanding – diluted |  | 45,403,085 |  |  | 37,448,430 |  |  | 36,403,279 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration